Zobrazeno 1 - 10
of 79
pro vyhledávání: '"L. Mondazzi"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gaetano Ideo, Antonio Rampoldi, Indira Rezakovic, A Alberti, Giorgio Brambilla, Riccardo Bottelli, L. Mondazzi, Claudio Zavaglia
Publikováno v:
Hepatology. 19:1115-1123
A total of 84 patients with hepatocellular carcinoma and cirrhosis were analyzed retrospectively to investigate prognostic factors. All patients received transarterial oily chemoembolization as the only anticancer therapy. The follow-up range was 1 t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d37a80fbcbc928b8679bf7a398e501e
https://doi.org/10.1002/hep.1840190508
https://doi.org/10.1002/hep.1840190508
Autor:
A. Bellobuono, Federico Chiodo, Lina Furione, L. Mondazzi, Gaetano Ideo, Enrico Magliano, S. Tempini
Publikováno v:
Journal of hepatology. 33(3)
Background/Aim: Persistence of HCV-RNA in serum early in treatment is a strong predictor of failure of α-interferon therapy for chronic hepatitis C. Therefore, we compared the efficacy of ribavirin addition to α-interferon with a doubling of the do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d3ad05b08d692d2f7656fd2b66be176
https://pubmed.ncbi.nlm.nih.gov/11020003
https://pubmed.ncbi.nlm.nih.gov/11020003
Autor:
Chiara Mondini, S. Tempini, A. Bellobuono, L. Mondazzi, Federico Chiodo, Enrico Magliano, Gaetano Ideo
Publikováno v:
Journal of hepatology. 30(1)
Retrospective studies have suggested that early loss of serum HCV-RNA predicts sustained response to alpha-interferon treatment in chronic hepatitis C, but the optimal duration of therapy after loss of HCV-RNA is not known. The aims of this study wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b677f2e605d9bc969a6432a3dad7889
https://pubmed.ncbi.nlm.nih.gov/9927145
https://pubmed.ncbi.nlm.nih.gov/9927145
Autor:
E, Fesce, A, Airoldi, L, Mondazzi, G, Maggi, G, Gubertini, G, Bernasconi, P, Del Poggio, F, Bozzetti, G, Idéo
Publikováno v:
Italian journal of gastroenterology and hepatology. 30(2)
The intramuscular use of beta interferon has been tested in the treatment of chronic hepatitis C, but it did not prove effective when the schedule was 3 million units three times a week for six months. Since the lack of effectiveness of this treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::35dfa575e2aa31c54a7ed084313fc897
https://pubmed.ncbi.nlm.nih.gov/9675656
https://pubmed.ncbi.nlm.nih.gov/9675656
Publikováno v:
European journal of gastroenterologyhepatology. 9(12)
Interferon alpha (IFN-alpha) provides effective treatment in some patients with chronic hepatitis C. Since this drug is costly and causes potentially severe side effects, there is a need for clarification of the optimal dose regimen and treatment dur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a7f11907787c7d2d6a3b19527597f802
https://pubmed.ncbi.nlm.nih.gov/9471022
https://pubmed.ncbi.nlm.nih.gov/9471022
Publikováno v:
Journal of viral hepatitis. 4(3)
Interferon-alpha (IFN-alpha) induces sustained remission of chronic hepatitis C in approximately 25% of patients. In patients who are non-responders to the first course of therapy, retreatment with IFN-alpha is of limited efficacy. Ribavirin has also
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c1f09d4fe50223041c63e654d67ca69
https://pubmed.ncbi.nlm.nih.gov/9181527
https://pubmed.ncbi.nlm.nih.gov/9181527
Autor:
Franco Gelosa, L. Mondazzi, Guido Colloredo, Claudio Zavaglia, Gianmaria Lamoni, Giorgio Bellati, Giovanni Maggi, Riccardo Bottelli, Gaetano Ideo
Publikováno v:
Liver. 17(2)
Paired sera and liver biopsies from 105 patients with chronic hepatitis B virus infection (34 HBeAg positive and 71 anti-HBe positive) were studied to investigate the relation between the degree of histological activity and alanine aminotransferase (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff822fa0565616b665cd14f143dcdc55
https://pubmed.ncbi.nlm.nih.gov/9138277
https://pubmed.ncbi.nlm.nih.gov/9138277
Autor:
C, Zavaglia, R, Bottelli, G, Bellati, L, Asti, L, Mondazzi, G, Iamoni, A, Zanetti, E, Tanzi, E, Fesce, F, Gelosa, G, Maggi, G, Ideo
Publikováno v:
The Italian journal of gastroenterology. 28(6)
Efficacy and safety of therapy with lymphoblastoid interferon-alpha alone or combined with deflazacort has been investigated in 38 HBsAg-HBeAg+ patients with biopsy-proven chronic hepatitis. Group I received 5 MU/m2 interferon thrice a week for 26 we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f08c4e31950517f236571d1245d160d2
https://pubmed.ncbi.nlm.nih.gov/8891847
https://pubmed.ncbi.nlm.nih.gov/8891847